Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

2024 ASH Annual Meeting Insights Hub
Avatar

ASH 2024 Insights: Hepcidin Mimetic Rusfertide in PV - Final Results of the Revive Study

By 2024 ASH Annual Meeting Insights Hub FEATURING Aaron Gerds
By 2024 ASH Annual Meeting Insights Hub FEATURING Aaron Gerds
69 views
December 18, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

15:11
Incyte

The Importance of Intervention at the First Signs of Initial Systemi…

Feat. P. Chaudhary
MDS and MPN
06:38

New

How I Treat Anemia in Myelofibrosis

Cleveland Clinic Taussig Cancer Institute

A. Jain

43 views
07:48

ASH 2024 Insights: Hepcidin Mimetic Rusfertide in PV - Final Results…

2024 ASH Annual Meeting Insights Hub

A. Gerds

69 views
10:06

New Therapeutic Targets Beyond JAK-STAT Inhibition in the Treatment …

Cleveland Clinic Taussig Cancer Institute

A. Gerds

402 views
16:58

JAK-STAT Inhibition in the Treatment of Ph-Negative MPN: What Are th…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

270 views
30:31

Somatic Mutations in MDS as a Diagnostic (ICUS, CHIP, CCUS) and Prog…

Cleveland Clinic Taussig Cancer Institute

V. Santini

146 views
28:01

The Changing Genomic Landscape of MPNs: Impact on Clinical Care

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

166 views
07:40

MPN, MDS and Aplastic Anemia Case Discussions

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

431 views
28:08

Rationale and Early Results of Innate Immunity and Immune Check Poin…

Cleveland Clinic Taussig Cancer Institute

G. Garcia-Manero

120 views
14:50

Novel Therapies Beyond Single Agent JAK Inhibitors: New Therapies an…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

309 views